Oral ascorbic acid as adjuvant to epoetin alfa in hemodialysis patients with hyperferritinemia.
Nguyen
Timothy V
TV
D000277:Adjuvants, Pharmaceutic / Q000008:administration & dosage / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D005293:Ferritins / Q000097:blood*; D006397:Hematinics / Q000627:therapeutic use*; D006454:Hemoglobins; D006801:Humans; D007275:Injections, Intravenous; D011994:Recombinant Proteins; D006435:Renal Dialysis
D000277:Adjuvants, Pharmaceutic; D006397:Hematinics; D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa; D005293:Ferritins; D001205:Ascorbic Acid